Kamada (KMDA) Change in Account Payables (2012 - 2026)

Kamada (KMDA) posted quarterly Change in Account Payables of -$1.4 million for Q1 2026, up 61.42% year-on-year from -$895803.0 in Q1 2025, and up 57.13% on a QoQ basis from -$3.4 million in Q4 2025.

Kamada (KMDA) Change in Account Payables (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Change in Account Payables for 15 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Account Payables rose 61.42% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (down 172.94% YoY) and the FY2025 annual result came in at -$6.9 million, down 660.36% from the prior year.
  • Change in Account Payables rose to -$1.4 million in Q1 2026 per KMDA's latest filing, from -$3.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for KMDA reached as high as $12.0 million in Q4 2024 and fell as low as -$13.6 million in Q1 2022.
  • A 5-year average of -$905753.8 and a median of -$6712.0 in 2023 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2023 — Change in Account Payables soared 985417.24% — and 2024, when it tumbled 130784.98%.
  • Year by year, Change in Account Payables stood at $1160.0 in 2022, then surged by 985417.24% to $11.4 million in 2023, then advanced by 4.73% to $12.0 million in 2024, then plunged by 128.17% to -$3.4 million in 2025, then soared by 57.13% to -$1.4 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$1.4 million, -$3.4 million, and $634000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -1.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.45 Mn
Mar 31, 2026 -1.45 Mn
Dec 31, 2025 -3.37 Mn
Dec 31, 2025 -3.37 Mn
Sep 30, 2025 634,000.00
Sep 30, 2025 634,000.00
Jun 30, 2025 -383,000.00
Jun 30, 2025 -383,000.00
Mar 31, 2025 -3.75 Mn
Mar 31, 2025 -3.75 Mn
Dec 31, 2024 11.97 Mn
Dec 31, 2024 11.97 Mn
Sep 30, 2024 -5.66 Mn
Sep 30, 2024 -5.66 Mn
Jun 30, 2024 3.69 Mn
Jun 30, 2024 3.69 Mn
Mar 31, 2024 -8.79 Mn
Mar 31, 2024 -8.79 Mn
Dec 31, 2023 11.43 Mn
Dec 31, 2023 11.43 Mn